BeStock  
Stocks › Cannabis & Hemp › HROW

Harrow HROW

US equityMarket cap rank #3066Cannabis & Hemp
$30.41 −$1.72 (-5.35%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.30 -0.36%
Open$31.95
Prev close$32.13
Day range$30.32 – $32.43
Volume911.8K
Market cap$1.14B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership60.7%+2.27 pts vs. prior quarter
Institutions holding256-8 vs. prior quarter
Insider trades (recent)32 buys / 18 sellsNet buying
Short interest18.92% of floatDays to cover 14.1 · as of 30 Oct 2026
Short-sale volume share26.2%5-day average of daily volume

Short-sale volume as % of daily volume

15%21%27%33%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$2.26M (11 inflow days, 9 outflow days).

Net flow by order size, last 20 sessions

+$2.4MSuper−$154.8KBig+$3.4MMid+$4.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 30.7% of shares outstanding.

Largest holders

  • Mark Baum7.98%
  • BlackRock7.88%
  • Opaleye Management Inc.5.61%
  • Daniel Kaufman5.00%
  • Private Capital Management, LLC4.26%
  • Vanguard Capital Management, LLC3.72%
  • State Street Global Advisors2.73%
  • Deep Track Capital, LP2.58%

By investor type

  • Mutual Fund42.33%
  • Individual/Insider16.41%
  • Hedge Fund12.08%
  • VC/PE Fund3.00%
  • Private Company1.23%
  • Public Company1.21%
  • Government Pension Fund0.55%
  • Insurance Company0.22%

Reported short interest has risen from 16.96% to 18.92% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Daniel Kaufman Individual/Insider 2026/Q3 +987,254 7.6%
Franklin Resources Mutual Fund 2026/Q3 +409,979 1.1%
Putnam LLC Mutual Fund 2026/Q3 +409,785 1.1%
FMR Mutual Fund 2026/Q3 +160,374 0.4%
Patient Square Capital, LP VC/PE Fund 2026/Q3 +145,000 0.4%
State Street Global Advisors Mutual Fund 2026/Q3 +84,951 2.7%
12th Street Asset Management LLC Mutual Fund 2026/Q3 +71,798 0.4%
Drive Wealth Management, LLC Mutual Fund 2026/Q3 +66,773 0.2%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +54,760 1.9%
Principal Global Investors, LLC Mutual Fund 2026/Q3 +52,806 0.3%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +64,696 0.2%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +969,000 2.6%
Baron Capital Group, Inc. Mutual Fund 2026/Q3 +809,350 2.2%
Janus Henderson Group plc Mutual Fund 2026/Q3 +565,627 1.5%
Divisadero Street Capital Management, LP Hedge Fund 2026/Q3 +439,155 1.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
13 Aug 2026 Amir Shojaei Chief Scientific Officer Derivative Exercise and Sale -11,250 $40.00 –
17 Jun 2026 Adrienne Graves Independent Director Other Derivative Acquisition +5,248 – 5,248
17 Jun 2026 Lauren Silvernail Independent Director Other Derivative Acquisition +5,248 – 5,248
17 Jun 2026 Perry Sternberg Lead Independent Director Other Derivative Acquisition +5,248 – 5,248
17 May 2026 Adrienne Graves Independent Director Open Market Acquisition +1,000 $31.07 1,000
17 May 2026 Lauren Silvernail Independent Director Open Market Acquisition +1,000 $31.00 1,000
14 May 2026 Amir Shojaei Chief Scientific Officer Other Derivative Acquisition +10,000 – 10,000
13 May 2026 Mark Baum CEO, Chairman of the Board & Founder Open Market Acquisition +10,000 $30.20 2,996,130
13 May 2026 Andrew Boll President, CFO & Chief Accounting Officer Open Market Acquisition +3,500 $29.90 814,679
3 Mar 2026 Opaleye Management Inc. Open Market Disposition -198,572 $39.67 3,681,428
26 Feb 2026 Opaleye Management Inc. Open Market Disposition -5,000 $54.18 3,880,000
5 Jan 2026 Opaleye Management Inc. Open Market Disposition -20,000 $53.35 3,885,000
11 Dec 2025 Mark Baum CEO, Chairman of the Board & Founder Derivative Exercise and Sale -79,994 $47.06 2,986,130
11 Dec 2025 Mark Baum CEO, Chairman of the Board & Founder Derivative Exercise and Retained +100,006 $3.95 2,986,130
11 Dec 2025 Andrew Boll President, CFO & Chief Accounting Officer Derivative Exercise and Sale -26,665 $47.06 811,179
11 Dec 2025 Andrew Boll President, CFO & Chief Accounting Officer Derivative Exercise and Retained +33,335 $3.95 811,179
31 Aug 2025 Randall Pollard Former Chief Accounting Officer Other Derivative Acquisition +30,000 $39.00 30,000
20 Jul 2025 Mark Baum CEO, Chairman of the Board & Founder Derivative Exercise and Sale -313,338 $37.08 2,886,124
20 Jul 2025 Mark Baum CEO, Chairman of the Board & Founder Derivative Exercise and Retained +286,662 $7.87 2,886,124
30 Jun 2025 Mark Baum CEO, Chairman of the Board & Founder Other Derivative Acquisition +889,500 – 889,500

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,092,437 18.9% 14.1
15 Oct 2026 7,474,800 19.9% 11.2
30 Sep 2026 7,762,798 20.7% 12.4
15 Sep 2026 7,488,381 20.0% 15.7
31 Aug 2026 6,778,977 18.1% 13.7
14 Aug 2026 6,358,236 17.0% 10.3

Discussion

No comments yet — be the first to weigh in on HROW.

Sign in to join the discussion.

Scroll to Top